This podcast series reveals the understated, but long-standing, and challenging problem of the lack of an effective technology for counting therapeutic tissue stem cells. It explores a secret that has been so well kept for so long by the stem cell research and stem cell medicine disciplines that many experts fail to even understand or acknowledge that the problem exists any more. In the podcast, with moderator Jordan Rich leading the expository discussion, Dr. James L. Sherley, M.D., Ph.D., Director and Founder of biotechnology tools company Asymmetrex, discloses the nature of the stem cell counting problem and its widespread detrimental effects in limiting progress in stem cell research, stem cell medicine, drug development, and environmental health sciences. Dr. Sherley also describes the recent development of a solution to the counting problem. Together, he and Jordan Rich consider both the immediate impact of the new stem cell counting technology and its future vision for advancing a near era of medicine.
All content for Counting Stem Cells is the property of Dr. James L. Sherley and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This podcast series reveals the understated, but long-standing, and challenging problem of the lack of an effective technology for counting therapeutic tissue stem cells. It explores a secret that has been so well kept for so long by the stem cell research and stem cell medicine disciplines that many experts fail to even understand or acknowledge that the problem exists any more. In the podcast, with moderator Jordan Rich leading the expository discussion, Dr. James L. Sherley, M.D., Ph.D., Director and Founder of biotechnology tools company Asymmetrex, discloses the nature of the stem cell counting problem and its widespread detrimental effects in limiting progress in stem cell research, stem cell medicine, drug development, and environmental health sciences. Dr. Sherley also describes the recent development of a solution to the counting problem. Together, he and Jordan Rich consider both the immediate impact of the new stem cell counting technology and its future vision for advancing a near era of medicine.
Additional Uses for Stem Cell Counting in Drug Development and Environmental Health Protection -005
Counting Stem Cells
6 minutes 49 seconds
5 years ago
Additional Uses for Stem Cell Counting in Drug Development and Environmental Health Protection -005
In the fifth episode, Asymmetrex director James L. Sherley and interviewer Jordan Rich expand their discussion of stem cell counting for stem cell medicine to consider how both traditional pharmaceutical drug development and environmental health analyses will also benefit from the new technology.
Counting Stem Cells
This podcast series reveals the understated, but long-standing, and challenging problem of the lack of an effective technology for counting therapeutic tissue stem cells. It explores a secret that has been so well kept for so long by the stem cell research and stem cell medicine disciplines that many experts fail to even understand or acknowledge that the problem exists any more. In the podcast, with moderator Jordan Rich leading the expository discussion, Dr. James L. Sherley, M.D., Ph.D., Director and Founder of biotechnology tools company Asymmetrex, discloses the nature of the stem cell counting problem and its widespread detrimental effects in limiting progress in stem cell research, stem cell medicine, drug development, and environmental health sciences. Dr. Sherley also describes the recent development of a solution to the counting problem. Together, he and Jordan Rich consider both the immediate impact of the new stem cell counting technology and its future vision for advancing a near era of medicine.
